Avaliação Da Ansiedade E Depressão De Pacientes Oncológicos Que Realizam Quimioterapia Ambulatorial

Kawakami, Débora Mayumi de Oliveira; Olah, Sabrina Lopes; Pivetta, Naelly Renata Saraiva; Silva, Renata Calciolari Rossi; Santos, Daiane Caroline N.; Napoleão, Layane Lopes; Padulla, Susimary Ap Trevizan

doi:10.5747/cv.2014.v06.n3.v109

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The analysis of the sample's sociodemographic profile showed characteristics similar to other studies that evaluated cancer patients (30)(31) , and observed a predominance of female patients, who live with a companion, and with 55 years as the mean age. These data confirm information from Inca, which points higher incidence of cancer in people over 40 years of age (1,(32)(33) .…”

Section: Discussionsupporting

confidence: 73%

Prevalence of symptoms and quality of life of cancer patients

et al. 2020

View full text Add to dashboard Cite

Objectives: to analyze the prevalence of symptoms and their relationship with the quality of life of cancer patients. Methods: this is a cross-sectional study with 107 patients evaluated using a sociodemographic instrument, the hospital anxiety and depression scale (HADS) and the quality of life scale (EORTC-QLQ-C30). Pearson’s correlation test was used to evaluate the relationship between symptoms and quality of life. Results: prevalence of female patients (56.1%), 55 years as the mean age and 10 years of schooling. Fatigue (76.6%), insomnia (47.7%), pain (42.1%), loss of appetite (37.4%), anxiety (31.8%) and depression (21.5%) were identified. Anxiety and depression symptoms presented a negative correlation with quality of life and positive correlation with physical symptoms. Conclusions: fatigue, insomnia, pain and loss of appetite were the most common and most intense symptoms. Anxiety and depression symptoms presented a negative correlation with quality of life and positive correlation with physical symptoms.

show abstract

Section: Discussionsupporting

confidence: 73%

Prevalence of symptoms and quality of life of cancer patients

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Another study that evaluated anxiety and depression in 50 patients who were being treated with chemotherapy drugs found that 38% of these probably had one or both mental disorders (KAWAKAMI et al, 2014). In the study by (TURKE et al, 2020), 24.24% of patients reported anxiety at high or borderline levels, similarly, 21.21% of depression.…”

Section: Harmony Of Knowledge Exploring Interdisciplinary Synergiesmentioning

confidence: 97%

Anxiety disorders and depression in patients undergoing cancer treatment using the hads scale: An integrative review

Amorim,

Kamiyama,

Eisenhardt

et al. 2024

Harmony of Knowledge: Exploring Interdisciplinary Synergie

View full text Add to dashboard Cite

Introduction: Psycho-Oncology as a subspecialty, which studies cancer patients and their physical, emotional, and psychological suffering. Such a state of anguish, when impactful, can lead to the development of mental disorders, such as anxiety and depression. Thus, with negative interference in daily life and worsening of quality of life, there may be difficulty in adhering to treatment, worsening the prognosis and survival of the patient. Objective: To analyze common mental disorders in cancer patients using the HADS scale. Methodology: The study consists of an integrative review of the scientific literature. The guiding question of the research determined by the PICO method was "What are the findings of the assessment of anxiety and depression by the Hospital Anxiety and Depression Scale (HADS) in patients undergoing cancer treatment?". Articles were searched in the following databases: LILACS, SciELO, PUBMED, Science Direct and CAPES Journals. The Health Sciences Descriptors used were: depression, anxiety, psycho-oncology, oncology and neoplasia. The included studies were full texts in English, Portuguese or Spanish, published between 2012 and October 2022. The use of the Hospital Scale for Anxiety and Depression (HADS) was used as a selection criterion. The data surveys were carried out in October and November 2022. The keywords were combined and the data found were read at the title level and, consequently, abstract. The articles selected by two independent evaluators were read in full and evaluated. In the end, the corpus consisted of 22 articles. Results and Discussion: The results of the review were subdivided into: symptoms of anxiety and depression, patients' perception of care, and the sociodemographic profile of cancer patients with psychiatric disorders. There is a higher prevalence of anxiety and depression in female cancer patients when compared to the general population. Anxiety symptoms were more prevalent in the immediate aftermath of diagnosis, and lower levels of anxiety were found throughout the course of the course and treatment. In addition, the need for a multidisciplinary approach and early application of Palliative Care is emphasized, in order to alleviate the suffering of those involved, corroborating the improvement of mental health. Conclusion: Psychiatric anxiety and depression disorders in patients undergoing cancer treatment are relevant pathologies to be researched due to their impact on cancer treatment adherence. Thus, the importance of a comprehensive approach to the patient, whether in the physical or emotional aspects through multidisciplinary follow-up, is noted, enabling greater well-being for the patient, resulting in the best treatment according to the need. Thus, we emphasize the need for further research on the subject, in order to update the findings according to the presence of new articles.

show abstract

Avaliação Da Ansiedade E Depressão De Pacientes Oncológicos Que Realizam Quimioterapia Ambulatorial

Cited by 2 publications

References 0 publications

Prevalence of symptoms and quality of life of cancer patients

Prevalence of symptoms and quality of life of cancer patients

Anxiety disorders and depression in patients undergoing cancer treatment using the hads scale: An integrative review

Contact Info

Product

Resources

About